Current Edition

Answering Pharma’s Need for Outsourcing to Process ‘Intensification’ Technology for the Future of Biopharmaceutical Production

The chemical and pharmaceutical industry will face challenges in the future related to manufacturing costs and lowering environmental impact. Chemical and biopharmaceutical manufacturing need to be modernised. This will bring lower raw material usage, higher yields with fewer resources, more focused manufacturing processes, and reduced manufacturing cost as final results. Fritjof Linz at DSM Biologics discusses how application of technologies brings down its manufacturing costs through process intensification to offer shorter and more efficient scale-up of (bio)pharmaceuticals, speeding up development, better managing manufacturing volumes and driving down total costs.